Assets 更改
Acadia Pharmaceuticals USD 748.96M 116.42M 2023-12
ALKERMES USD 2.28B 92.05M 2023-09
BioCryst Pharmaceuticals USD 522.92M 6.96M 2023-09
Biogen USD 26.84B 1.35B 2023-12
Bristol-Myers Squibb USD 91.26B 2.23B 2023-09
Cytokinetics USD 824.32M 83.7M 2023-12
Esperion Therapeutics USD 221.3M 13.32M 2023-09
Gilead Sciences USD 62.13B 248M 2023-12
Halozyme Therapeutics USD 1.73B 159.39M 2023-12
Intra Cellular Therapies USD 728.3M 10.63M 2023-12
J&J USD 166.06B 25.62B 2023-09
Marinus Pharmaceuticals USD 200.81M 394K 2023-09
Minerva Neurosciences USD 63.13M 4.01M 2023-09
Nektar Therapeutics USD 442.24M 52.04M 2023-09
Neurocrine Biosciences USD 2.85B 235.1M 2023-09
RedHill Biopharma USD 35.04M 23.8M 2023-06
Supernus Pharmaceuticals USD 1.28B 7.49M 2023-12
United Therapeutics USD 7.17B 143.4M 2023-12
Vanda Pharmaceuticals USD 641.68M 2.85M 2023-06



Intra Cellular Therapies 资产 - 当前值,历史数据,预测,统计,图表和经济日历 - Mar 2024.